These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25213262)

  • 1. Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid.
    Undas A; Brummel-Ziedins K; Mann KG
    J Thromb Haemost; 2014 Nov; 12(11):1776-87. PubMed ID: 25213262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5000 years old and still going strong.
    Rosendaal FR; Reitsma PH
    J Thromb Haemost; 2014 Nov; 12(11):1763. PubMed ID: 25385397
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and recurrent venous thromboembolism.
    Prandoni P; Noventa F; Milan M
    Phlebology; 2013 Mar; 28 Suppl 1():99-104. PubMed ID: 23482543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System.
    Perrella G; Nagy M; Watson SP; Heemskerk JWM
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2681-2692. PubMed ID: 34496636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
    Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
    Mai V; Bertoletti L; Cucherat M; Jardel S; Grange C; Provencher S; Lega JC
    PLoS One; 2019; 14(4):e0214134. PubMed ID: 30933993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.
    Weisshaar S; Litschauer B; Gouya G; Mayer P; Smerda L; Kapiotis S; Kyrle PA; Eichinger S; Wolzt M
    J Thromb Haemost; 2014 Nov; 12(11):1850-60. PubMed ID: 25211369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic medications and their impact on fibrin clot structure and function.
    Undas A; Zabczyk M
    J Physiol Pharmacol; 2018 Aug; 69(4):. PubMed ID: 30415236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Insights Into the Regulation of Coagulation and Thrombosis.
    Li X; Sim MMS; Wood JP
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):e119-e125. PubMed ID: 32320291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
    Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
    Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence.
    Stewart DW; Freshour JE
    Ann Pharmacother; 2013 Jan; 47(1):63-74. PubMed ID: 23324504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.
    Rollini F; Franchi F; Cho JR; Degroat C; Bhatti M; Ferrante E; Patel R; Darlington A; Tello-Montoliu A; Desai B; Ferreiro J; Muniz-Lozano A; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ
    J Cardiovasc Transl Res; 2014 Feb; 7(1):53-63. PubMed ID: 24395495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized antithrombotic therapy.
    Lüscher TF; Steffel J
    Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspirin and prevention of the recurrence of venous thromboembolism].
    Ben Salah R; Derbel A; Chabchoub I; Frikha F; Marzouk S; Bahloul Z
    Ann Cardiol Angeiol (Paris); 2024 Jun; 73(3):101761. PubMed ID: 38754180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer.
    Ma R; Bi Y; Kou J; Zhou J; Shi J
    Cancer Biol Ther; 2017 Aug; 18(8):627-634. PubMed ID: 28718695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis and antithrombotic therapy in women.
    Bailey AL; Scantlebury DC; Smyth SS
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):284-8. PubMed ID: 19221205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelets and arterial thrombosis].
    Cazenave JP; Gachet C; Lanza F; Wiesel ML
    Bull Acad Natl Med; 2003; 187(1):35-44; discussion 45-6. PubMed ID: 14556452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
    Wójcik M; Zaręba L; Undas A
    Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.